Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing randomized placebo-controlled trial of fiblyzyme injection in acute ischemic stroke
ChiCTR2100042526Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 1990
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Fiblyzyme in ischemic stroke (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: 3-month modified Rankin Scale score and Bleeding events during medication defined by PLATO. Started Jan 1990; status: recruiting.
02
Drugs
Fiblyzyme
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100042526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042526.